BVMF/HYPE3 (BVMF/HYPE3)

Brazil Stock Exchange: BVMF/HYPE3 · BRL

R$21.5

-0.03 (-0.1%)· Recorded snapshot

Market cap	15.1B
Revenue (ttm)	9B
Net income (ttm)	1.8B
EPS (ttm)	R$2.69
Shares out	704M
P/E (trailing)	8.0x
P/E (forward)	6.8x
Dividend	R$1.17 (5.44%)
Volume	1,377,200
Beta	0.07

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 9B
Net income (ttm): 1.8B
EPS (ttm): R$2.69
P/E (trailing): 8.0x
P/E (forward): 6.8x
Market cap: 15.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/E6.8

P25 n/aP50 n/aP75 n/a

Trailing P/E8

P25 n/aP50 n/aP75 n/a

ROE13.4

P25 n/aP50 n/aP75 n/a

ROIC12.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/HYPE3 indicators

Market & fundamental data

Available fields

264

Groups with data

Currency

BRL

Showing 264 of 264 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	Brazil
Country code	BR
Earnings date	2026-10-27
Employees	10,564
Employees change	83
Employees growth	0.79%
Enterprise value	BRL 20.7B
Exchange	Brazil Stock Exchange
Financial currency	BRL
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1999
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	BRHYPEACNOR0
Last earnings date	2026-10-27
Last refreshed	2026-10-30
Last stock split date	2010-01-04
Last stock split type	Forward
Market cap	BRL 15.1B
Next earnings date	2027-03-12
Price	BRL 21.49
Price currency	BRL
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-30
Symbol	bvmf/HYPE3
Website	https://www.hypera.com.br

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	7.93x
Average P/E ratio (10Y)	18.31x
Average P/E ratio (3Y)	12.65x
Average P/E ratio (5Y)	13.95x
Earnings yield	12.49%
EV/Earnings	11.44x
EV/EBIT	8.13x
EV/EBITDA	7.3x
EV/FCF	8.61x
EV/Sales	2.3x
FCF / EV yield	11.61%
FCF yield	15.91%
Forward P/E	6.77x
Graham number	35.76642
Graham upside	66.2%
Lynch fair value	BRL 18.87
Lynch upside	-12.33%
P/(FCF - SBC) ratio	6.31x
P/(OCF - SBC) ratio	5.41x
P/B ratio	1.03x
P/E ratio	8x
P/FCF ratio	6.28x
P/OCF ratio	5.39x
P/S ratio	1.68x
PEG ratio	0.28x
Price / tangible book value	6.04x
Price/EBITDA ratio	5.5x
Sector forward P/E	10.79x
Sector P/E	32.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	28.12%
EBITDA margin	30.53%
FCF margin	26.7%
Gross margin	61.22%
Operating margin	28.12%
Pretax margin	19.56%
Profit margin	20.11%
Profit per employee	BRL 171,833
Profitable quarters	6
Profitable years	14
Revenue per employee	BRL 854,540
ROA	6.16%
ROA (5Y)	5.77%
ROCE	11.3%
ROE	13.41%
ROE (5Y)	13.89%
ROIC	12.41%
ROIC (5Y)	12.29%
SBC / revenue	0.11%
Tax / revenue	-0.51%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	107.49%
EPS growth (Q)	4.29%
EPS growth (QoQ)	7.2%
EPS growth 10Y	0.32%
EPS growth 3Y	-1.02%
EPS growth 5Y	6.1%
EPS growth quarters	5
EPS growth years	0
FCF growth	21.87%
FCF growth (Q)	-16.25%
FCF growth (QoQ)	-16.2%
FCF growth 3Y	14.68%
FCF growth 5Y	25.21%
Gross profit growth	39.77%
Gross profit growth (Q)	9.67%
Gross profit growth 3Y	2.24%
Gross profit growth 5Y	9.67%
Net income growth	120.98%
Net income growth (Q)	14.32%
Net income growth (QoQ)	6.71%
Net income growth 3Y	0.87%
Net income growth 5Y	7.03%
Net income growth quarters	5
Net income growth years	0
OCF growth	9.61%
OCF growth (Q)	-10.64%
OCF growth (QoQ)	-6.89%
OCF growth 10Y	13.01%
OCF growth 3Y	9.89%
OCF growth 5Y	16.8%
Operating income growth	119.76%
Operating income growth (Q)	4.01%
Operating income growth 3Y	-1.02%
Operating income growth 5Y	9.43%
Revenue growth	29.46%
Revenue growth (Q)	9.36%
Revenue growth (QoQ)	4.24%
Revenue growth 10Y	10.92%
Revenue growth 3Y	3.3%
Revenue growth 5Y	10.64%
Revenue growth quarters	5
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -400.4M
Depreciation and amortization	BRL 217.9M
EBIT	BRL 2.5B
EBITDA	BRL 2.8B
EPS	BRL 2.69
FCF per share	BRL 3.42
Financing cash flow	BRL -2B
Free cash flow	BRL 2.4B
Free cash flow minus SBC	BRL 2.4B
Gross profit	BRL 5.5B
Income taxes	BRL -46.4M
Investing cash flow	BRL -588.5M
Net borrowing	BRL -1.3B
Net cash flow	BRL 183.8M
Net income	BRL 1.8B
Operating cash flow minus SBC	BRL 2.8B
Operating income	BRL 2.5B
Revenue	BRL 9B
Stock-based compensation	BRL 9.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.73
Book value per share	BRL 21.17
Debt / EBITDA	2.71
Debt / equity	0.52
Debt / FCF	3.18
Interest coverage	2.57
Long-term assets	BRL 19.6B
Long-term liabilities	BRL 7.7B
Net cash (debt)	BRL -5.6B
Net cash / market cap	-37.03%
Net debt / EBITDA	2.04
Net debt / equity	0.38
Net debt / FCF	2.33
Piotroski F-Score	8
Property, plant and equipment	BRL 4.5B
Shareholders' equity	BRL 14.8B
Tangible book value	BRL 2.5B
Tangible book value per share	BRL 3.60
Total assets	BRL 26.3B
Total cash	BRL 2B
Total debt	BRL 7.7B
Total liabilities	BRL 11.6B
WACC	6.5%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.35
Current assets	BRL 6.7B
Current liabilities	BRL 3.9B
Current ratio	1.73
Inventory turnover	1.72
Net working capital	BRL 1.3B
Quick ratio	1.17
Working capital	BRL 2.8B
Working capital turnover	4.35

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-6.5%
Dividend growth	-7.42%
Dividend growth (10Y)	8.02%
Dividend growth (3Y)	-4.23%
Dividend growth (5Y)	-2.35%
Dividend growth years	1
Dividend payment years	11
Dividend payout frequency	Quarterly
Dividend per share	BRL 1.17
Dividend yield	5.44%
Ex-dividend date	2026-09-29
FCF payout ratio	31.59%
Last dividend	BRL 0.26
Payout ratio	41.54%
Shareholder yield	-1.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-20.06%
10Y return CAGR	2.17%
10Y total return	23.96%
150-day SMA	BRL 22.51
15Y price change	117.15%
15Y return CAGR	8.63%
15Y total return	246.18%
1D price change	-0.14%
1M price change	-9.31%
1M total return	-9.31%
1W price change	-21.03%
1W total return	-21.03%
1Y price change	-12.02%
1Y return CAGR	-6.84%
1Y total return	-6.84%
20-day SMA	BRL 25.18
200-day SMA	BRL 22.74
3M price change	2.33%
3M total return	3.44%
3Y price change	-31.4%
3Y return CAGR	-7.29%
3Y total return	-20.31%
50-day SMA	BRL 23.89
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 30.00
52-week high date	2026-10-05
52-week low	BRL 19.41
52-week low date	2026-10-26
5Y price change	-23.31%
5Y return CAGR	-1.04%
5Y total return	-5.08%
6M price change	-5.32%
6M total return	-3.12%
All-time high	BRL 51.11
All-time high date	2022-10-31
All-time low	BRL 4.55
All-time low date	2008-10-16
Average true range (ATR)	BRL 1.27
Average volume	6.4M
Beta (1Y)	0.12
Beta (2Y)	0.24
Beta (5Y)	0.07
Change from 52-week high	-28.37%
Change from 52-week low	10.72%
Change from all-time high	-57.89%
Change from all-time low	372.97%
Change from open	1.03%
Day's gap	-1.16%
Dollar volume	BRL 29.6M
High price	BRL 21.49
Low price	BRL 21.27
Monthly RSI	43.19
Open price	BRL 21.27
Position in 52-week range	100%
Previous close	BRL 21.52
Price vs 150-day SMA	-4.4%
Price vs 20-day SMA	-14.55%
Price vs 200-day SMA	-5.35%
Price vs 50-day SMA	-9.92%
Relative volume	0.22
RSI	36.62
Sharpe ratio	0.03
Sharpe ratio (3Y)	-0.21
Sharpe ratio (5Y)	-0.02
Sortino ratio	0.15
Sortino ratio (3Y)	-0.13
Sortino ratio (5Y)	0.14
Volume	1.4M
Weekly RSI	44.56
YTD price change	-8.66%
YTD total return	-4.49%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	305.7M
Shares change (QoQ)	-0.45%
Shares change (YoY)	6.5%
Shares held by insiders	26.05%
Shares held by institutions	25.51%
Shares outstanding	704M

Deeper analysis on BVMF/HYPE3

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/HYPE3 report

Is a complete BVMF/HYPE3 research report available?

No complete published report is available for bvmf/HYPE3 (BVMF/HYPE3) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/HYPE3 (BVMF/HYPE3)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/HYPE3

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/HYPE3 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/HYPE3

Frequently asked questions